Does Cytoreductive Prostatectomy Really Have an Impact on Prognosis in Prostate Cancer Patients with Low-volume Bone Metastasis? Results from a Prospective Case-Control Study.
暂无分享,去创建一个
A. Haese* | T. Schlomm | H. Heinzer | M. Graefen | G. Salomon | T. Steuber | L. Budäus | H. Huland | K. Brasso | K. D. Berg | M. Røder | P. Iversen | P. Mandel | D. Tilki | Anne-Kathrin Tiebel
[1] F. Montorsi,et al. Radical Prostatectomy in Men with Oligometastatic Prostate Cancer: Results of a Single-institution Series with Long-term Follow-up. , 2017, European urology.
[2] R. Miralbell,et al. Prognostic value of biochemical response to neoadjuvant androgen deprivation before external beam radiotherapy for prostate cancer: A systematic review of the literature. , 2016, Cancer treatment reviews.
[3] F. Montorsi,et al. A Multi-institutional Analysis of Perioperative Outcomes in 106 Men Who Underwent Radical Prostatectomy for Distant Metastatic Prostate Cancer at Presentation. , 2016, European urology.
[4] B. Vainer,et al. The predictive value of ERG protein expression for development of castration‐resistant prostate cancer in hormone‐naïve advanced prostate cancer treated with primary androgen deprivation therapy , 2015, The Prostate.
[5] D. Pfister,et al. Cytoreductive radical prostatectomy in patients with prostate cancer and low volume skeletal metastases: results of a feasibility and case-control study. , 2015, The Journal of urology.
[6] M. Menon,et al. Identifying optimal candidates for local treatment of the primary tumor among patients diagnosed with metastatic prostate cancer: a SEER-based study. , 2015, European urology.
[7] C. Stief,et al. Role of radical prostatectomy in metastatic prostate cancer: data from the Munich Cancer Registry. , 2014, European urology.
[8] P. Schellhammer,et al. Might men diagnosed with metastatic prostate cancer benefit from definitive treatment of the primary tumor? A SEER-based study. , 2014, European urology.
[9] P. de Souza,et al. Primary treatment of the prostate improves local palliation in men who ultimately develop castrate‐resistant prostate cancer , 2013, BJU international.
[10] M. Dimopoulos,et al. Time to castration resistance is an independent predictor of castration-resistant prostate cancer survival. , 2011, Anticancer research.